Exclusive agreement with the Menarini group and Berlin Chemie for Sitavig®Read the press releasePress releases - 03/07/2023
Exclusive agreement with Berlin Chemie for Sitavig® in Eastern Europe and the CIS regionRead the press releasePress releases - 09/20/2022
Navamedic ASA – Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig®Read the press releasePress releases - 08/26/2022
Nomination of François Boutignon as Chief Innovation and Technology OfficerRead the press releasePress releases - 03/24/2022
Exclusive licensing agreement with m8 PharmaceuticalsRead the press releasePress releases - 02/03/2020